Thermo Fisher Scientific | TMO - Interest Expense On Debt


Thermo Fisher Scientific reported $354M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Agilent USD 25M 0 Mar/2026
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Bio Techne USD 2.17M 9K Dec/2025
Bio-Rad Laboratories USD 12.1M 200K Dec/2025
Boston Scientific USD 90M 0 Mar/2026
Bruker USD 8.1M 11.9M Dec/2025
Charles River Laboratories USD 26.74M 2.97M Mar/2026
Danaher USD 63M 8M Mar/2026
Dentsply International USD 24M 2M Mar/2026
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
General Electric Aerospace USD 496M 271M Dec/2025
Henry Schein USD 39M 0 Mar/2026
Illumina USD 26M 1000K Dec/2025
Intuitive Surgical USD 20.11B 58.39B Mar/2026
IQVIA Holdings USD 192M 1000K Mar/2026
Laboratory Of America USD 55.1M 100K Mar/2026
Medtronic USD 176M 5M Mar/2026
Mettler Toledo International USD 17.39M 307K Dec/2025
Myriad Genetics USD 4.4M 600K Dec/2025
Olympus JPY 516M 1.83B Mar/2026
OraSure Technologies 1.67M 1.13M Dec/2025
Quest Diagnostics USD 69M 2M Sep/2025
Repligen USD 5.58M 83K Mar/2026
Revvity USD 24.72M 1.2M Mar/2026
Stryker USD 46.29B 45.68B Mar/2026
Thermo Fisher Scientific USD 354M 11M Mar/2026
Veracyte USD 2K 1000 Dec/2023
Waters USD 42M 33.38M Mar/2026
Zimmer Biomet Holdings USD 68.8M 3.1M Mar/2026